BioSpace News Archive

Controlled Substance Market: Pain Management Increases Scope of Opioid Treatment for Advanced Cancer Patients

Some prescription medicines are controlled under the Misuse of Drugs legislation. These medicines are called controlled substances or controlled drugs. Doctors can prescribe all controlled medicines to treat an illness or injury.

April 30, 2020
·
6 min read
Pharmacovigilance Market - High Prevalence of Chronic Diseases to Augur Well for the Pharmacovigilance Market

According to the World Health Organization, Pharmacovigilance is the activities and science about the prevention, understanding, assessment, and detention of adverse effects or any other problem related to drugs.

April 30, 2020
·
4 min read
BioCapital

ILC Dover Responds to PPE Shortage for Healthcare Workers, Expedites Manufacturing of New PAPR Hood

ILC Dover, a world leader in the innovative design and production of engineered products employing high-performance flexible materials, announced that it expedited the regulatory approval and manufacturing processes of a new Powered Air Purifying Respirator hood for healthcare workers attending to patients with COVID-19.

April 30, 2020
·
2 min read
Deals

Bio-Techne Declares Dividend - April 30, 2020

Bio-Techne Corporation announced that its Board of Directors has decided to pay a dividend of $0.32 per share for the quarter ended March 31, 2020.

April 30, 2020
·
1 min read
Drug Development

Annovis Bio Announces Plans for a New Phase II Clinical Trial to Treat 68 Parkinson’s and Alzheimer’s Patients

Annovis Bio Inc., a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, announced that the protocol for its Phase 2 clinical study in PD and AD patients was submitted to the U.S. Food and Drug Administration.

April 30, 2020
·
4 min read
Business

TTP plc Collaborates with ODx to Develop New Technology to Address Antibiotic Resistance

System for assessing urinary tract infections at the point of care, and determining optimal antibiotic course, is on track for initial trials in 2020

April 30, 2020
·
3 min read
Business

STERIS to Host a Conference Call for Fiscal 2020 Fourth Quarter and Full Year Financial Results on May 14, 2020

STERIS plc announced that it will host a conference call to discuss its fiscal 2020 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Thursday, May 14, 2020.

April 30, 2020
·
6 min read
Business

Agios Reports First Quarter 2020 Financial Results and Provides Update on Business Operations and COVID-19 Response

First Quarter TIBSOVO® Net Revenue of $22.7 Million; Company Reiterates 2020 TIBSOVO® Net U.S. Revenue Guidance of $105–115 Million

April 30, 2020
·
17 min read
Business

Genocea Provides First Quarter 2020 Corporate Update

Genocea Biosciences, Inc., a biopharmaceutical company developing next-generation neoantigen immunotherapies, reported its operating and financial results for the first quarter ended March 31, 2020.

April 30, 2020
·
5 min read
Pharm Country

Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI

122 Subject, Multicenter, Double-Blind, Randomized, Clinical Trial Finds PoNS Treatment™ Provides Significant Improvement in Balance and Gait Deficits for Individuals Who Have Experienced a Mild-to-Moderate Traumatic Brain Injury

April 30, 2020
·
7 min read